Nasdaq
$0.1880▼ 0.63%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $3.5MShares out 18.6M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
8- 5d agoPre-market26.10.19 22:09SCHEDULE 13GOwnership#●●●#●●●
KALA BIO, Inc.
Nachum Labkowski has filed a Schedule 13G regarding their beneficial ownership in KALA BIO, Inc. The filing confirms the reporting person's stake in the company as of October 19, 2026.…more
$0.1880-0.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24After-hours26.09.25 05:10DEF 14AOther
KALA BIO, Inc.
KALA BIO will hold its 2026 annual meeting of stockholders on November 3, 2026, to vote on several proposals, including the approval of a reverse stock split of its common stock at a ratio between 1-for-2 and 1-for-300. Other agenda items include the election of directors, an advisory vote on executive compensation, and the ratification of the independent registered public accounting firm.…more
$0.1880-0.63%vs prev closeView filingShare - 9.11After-hours26.09.12 05:56PRE 14AOther
KALA BIO, Inc.
KALA BIO will hold its 2026 annual meeting of stockholders on November 3, 2026, to vote on a proposal for a reverse stock split. The split ratio is set between 1-for-2 and 1-for-300, with the board of directors authorized to determine the exact ratio and timing.…more
$0.1880-0.63%vs prev closeView filingShare
7 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 9.30Overnight26.09.30 14:17#●●●#●●●
KALA Bio Shares Surge 57% on Proposed Telehealth Platform Acquisition
KALA Bio shares jumped 57% in after-hours trading following the announcement of a non-binding letter of intent to acquire a telehealth platform for $15 million. As the agreement is currently non-binding, investors should monitor the progress of the due diligence process and final closing.…more
$0.1880-0.63%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.29Pre-market26.09.29 20:33
●●●●●●●● ●●●●● ●●●●●●
KALA Bio has signed a non-binding letter of intent to acquire a U.S.-based management services organization for approximately $15 million. The target company generated about $12.7 million in revenue over the trailing twelve months.…more
$0.1880-0.63%vs prev closeShareBenzinga - 9.24Pre-market26.09.24 20:30
●●●●●●●● ●●●●● ●●●●●●
Kala Bio has signed a non-binding letter of intent to resell Virotek's genomic testing products through a U.S. DNA testing platform. The agreement is in the early stages, with commercial terms and final contracts still under negotiation.…more
$0.1880-0.63%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report